Theravance Biopharma
TBPH
#7077
Rank
โ‚น37.19 B
Marketcap
Country
โ‚น756.35
Share price
-2.98%
Change (1 day)
-7.15%
Change (1 year)

Theravance Biopharma (TBPH) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น7.87 Billion

According to Theravance Biopharma 's latest financial reports the company has โ‚น7.87 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Theravance Biopharma - Cash on Hand chart (from 2013 to 2024)

201620192022โ‚น10Bโ‚น20Bโ‚น30Bโ‚น40B0companiesmarketcap.com

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น8.52 B-68.53%
2022-12-31โ‚น27.09 B109.89%
2021-12-31โ‚น12.91 B-39.73%
2020-12-31โ‚น21.42 B6.98%
2019-12-31โ‚น20.02 B-43.32%
2018-12-31โ‚น35.33 B58.74%
2017-12-31โ‚น22.25 B-34.64%
2016-12-31โ‚น34.05 B197.16%
2015-12-31โ‚น11.45 B-28.99%
2014-12-31โ‚น16.13 B
2013-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น10.33 B 31.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น32.76 B 316.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น38.10 B 384.16%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น28.85 B 266.68%๐Ÿ‡บ๐Ÿ‡ธ USA